Prognostic value of serum oncomarkers for patients hospitalized with acute exacerbation of interstitial lung disease.

ABSTRACT:

Background

Different types of inflammatory processes and fibrosis have been implicated in the pathogenesis of interstitial lung disease (ILD), a heterogeneous, diffuse, parenchymal lung disease. Acute exacerbation (AE) of ILD is characterized by significant respiratory deterioration and is associated with high mortality rates. Several serum oncomarkers have been used to determine the prognosis of ILD; however, the prognostic value of serum oncomarker levels in patients with AE-ILD remains unclear.

Objective

To evaluate the prognostic value of serum oncomarker levels in patients with AE-ILD and its main subtypes.

Design

Retrospective study.

Methods

The serum levels of 8 oncomarkers in 281 patients hospitalized with AE-ILD at our institution between 2017 and 2022

SUBMITTER: Ba C 

PROVIDER: S-EPMC11102678 | biostudies-literature | 2024 Jan-Dec

REPOSITORIES: biostudies-literature